Company intelligence / Profile preview

Zhejiang Ideal Biotech

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Zhejiang Ideal Biotech is a clinical-stage biopharmaceutical company based in China, primarily focused on the development of innovative small molecule therapies for metabolic diseases. The company's research and development efforts are centered on high-prevalence conditions such as type 2 diabetes, obesity, and nonalcoholic steatohepatitis (NASH). Its lead programs include novel GLP-1 receptor agonists and other metabolic regulators designed to provide improved efficacy and safety profiles over existing treatments. Ideal Biotech leverages its internal R&D capabilities to advance a pipeline of candidates through clinical trials in the Chinese market.

Therapeutic areas: EndocrinologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Zhejiang Ideal Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Ideal Biotech.

Explore the full profile